Myeloid expression of angiotensin-converting enzyme facilitates myeloid maturation and inhibits the development of myeloid-derived suppressor cells

Laboratory Investigation

Volumn 94, Issue 5, 2014, Pages 536-544

  Shen, Xiao Z ^a   Okwan Duodu, Derick ^a,b   Blackwell, Wendell Lamar ^a   Ong, Frank S ^a   Janjulia, Tea ^a   Bernstein, Ellen A ^a   Fuchs, Sebastien ^a   Alkan, Serhan ^a   Bernstein, Kenneth E ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

angiotensin converting enzyme; macrophages; myeloid derived suppressor cells

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; FREUND ADJUVANT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD; BONE MARROW CELL; CELL COUNT; CELL MATURATION; CHRONIC INFLAMMATION; CONTROLLED STUDY; ENZYME ACTIVITY; GENE OVEREXPRESSION; IN VITRO STUDY; IN VIVO STUDY; MACROPHAGE; MELANOMA CELL LINE; MONOCYTE; MOUSE; MYELOID DERIVED SUPPRESSOR CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN; SUPPRESSOR CELL; TUMOR GROWTH; TUMOR MODEL;

ANIMALS; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; MYELOID PROGENITOR CELLS; MYELOPOIESIS; PEPTIDYL-DIPEPTIDASE A; PHENOTYPE;

EID: 84899545671     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2014.41     Document Type: Article

References (29)

1. Shen XZ, Ong FS, Bernstein EA, et al. Nontraditional roles of angiotensin-converting enzyme. Hypertension 2012;59:763-768.
2. Platten M, Youssef S, Hur EM, et al. Blocking angiotensin-converting enzyme induces potent regulatory T cells and modulates TH1-and TH17-mediated autoimmunity. Proc Natl Acad Sci USA 2009;106: 14948-14953.
3. Lin C, Datta V, Okwan-Duodu D, et al. Angiotensin-converting enzyme is required for normal myelopoiesis. FASEB J 2011;25:1145-1155.
4. Bernstein KE, Ong FS, Blackwell WL, et al. A modern understanding of the traditional and nontraditional biological functions of angiotensinconverting enzyme. Pharmacol Rev 2013;65:1-46.
5. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003;299: 1057-1061.
6. Gabrilovich DI, Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 2009;9:162-174.
7. Otsuji M, Kimura Y, Aoe T, et al. Oxidative stress by tumor-derived macrophages suppresses the expression of CD3 zeta chain of T-cell receptor complex and antigen-specific T-cell responses. Proc Natl Acad Sci USA 1996;93:13119-13124.
8. Pak AS, Wright MA, Matthews JP, et al. Mechanisms of immune suppression in patients with head and neck cancer: presence of CD34(\+) cells which suppress immune functions within cancers that secrete granulocyte-macrophage colony-stimulating factor. Clin Cancer Res 1995;1:95-103.
9. Marigo I, Dolcetti L, Serafini P, et al. Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells. Immunol Rev 2008;222:162-179.
10. Delano MJ, Scumpia PO, Weinstein JS, et al. MyD88-dependent expansion of an immature GR-1(\+)CD11b(\+) population induces T cell suppression and Th2 polarization in sepsis. J Exp Med 2007;204:1463-1474.
11. Munera V, Popovic PJ, Bryk J, et al. Stat 6-dependent induction of myeloid derived suppressor cells after physical injury regulates nitric oxide response to endotoxin. Ann Surg 2010;251:120-126.
12. Pastor S, Minguela A, Mi W, et al. Autoantigen immunization at different sites reveals a role for anti-inflammatory effects of IFN-gamma in regulating susceptibility to experimental autoimmune encephalomyelitis. J Immunol 2009;182:5268-5275.
13. Gabrilovich DI, Velders MP, Sotomayor EM, et al. Mechanism of immune dysfunction in cancer mediated by immature Gr-1\+ myeloid cells. J Immunol 2001;166:5398-5406.
14. Youn JI, Gabrilovich DI. The biology of myeloid-derived suppressor cells: the blessing and the curse of morphological and functional heterogeneity. Eur J Immunol 2010;40:2969-2975.
15. Shen XZ, Li P, Weiss D, et al. Mice with enhanced macrophage angiotensin-converting enzyme are resistant to melanoma. Am J Pathol 2007;170:2122-2134.
16. Esther CR, Howard TE, Marino EM, et al. Mice lacking angiotensinconverting enzyme have low blood pressure, renal pathology, and reduced male fertility. Lab Invest 1996;74:953-965.
17. Marigo I, Bosio E, Solito S, et al. Tumor-induced tolerance and immune suppression depend on the C/EBPbeta transcription factor. Immunity 2010;32:790-802.
18. Youn JI, Nagaraj S, Collazo M, et al. Subsets of myeloid-derived suppressor cells in tumor-bearing mice. J Immunol 2008;181: 5791-5802.
19. Shen XZ, Billet S, Lin C, et al. The carboxypeptidase ACE shapes the MHC class I peptide repertoire. Nat Immunol 2011;12:1078-1085.
20. Roth F, De La Fuente AC, Vella JL, et al. Aptamer-mediated blockade of IL4Ra triggers apoptosis of MDSCs and limits tumor progression. Cancer Res 2012;72:1373-1383.
21. Priceman SJ, Sung JL, Shaposhnik Z, et al. Targeting distinct tumor-infiltrating myeloid cells by inhibiting CSF-1 receptor: combating tumor evasion of antiangiogenic therapy. Blood 2010;115: 1461-1471.
22. Movahedi K, Guilliams M, Van den Bossche J, et al. Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity. Blood 2008;111: 4233-4244.
23. Dolcetti L, Peranzoni E, Ugel S, et al. Hierarchy of immunosuppressive strength among myeloid-derived suppressor cell subsets is determined by GM-CSF. Eur J Immunol 2010;40:22-35.
24. Van Rooijen N, Sanders A. Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. J Immunol Methods 1994;174:83-93.
25. Cheng P, Corzo CA, Luetteke N, et al. Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein. J Exp Med 2008;205: 2235-2249.
26. Qian BZ, Pollard JW. Macrophage diversity enhances tumor progression and metastasis. Cell 2010;141:39-51.
27. Sonda N, Chioda M, Zilio S, et al. Transcription factors in myeloidderived suppressor cell recruitment and function. Curr Opin Immunol 2011;23:279-285.
28. Corzo CA, Condamine T, Lu L, et al. HIF-1a regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment. J Exp Med 2010;207:2439-2453.
29. Youn JI, Kumar V, Collazo M, et al. Epigenetic silencing of retinoblastoma gene regulates pathologic differentiation of myeloid cells in cancer. Nat Immunol 2013;14:211-220.